The weekly litigation news digest is live. Subscribe now

Use Of Trl Agonist And Anti-Cd47 Agent To Enhance Phagocytosis Of Cancer Cells - EP3656443

The patent EP3656443 was granted to The Board OF Trustees OF The Leland Stanford Junior University on Sep 29, 2021. The application was originally filed on Jan 21, 2016 under application number EP19197485A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3656443

THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
Application Number
EP19197485A
Filing Date
Jan 21, 2016
Status
Granted And Under Opposition
Aug 27, 2021
Publication Date
Sep 29, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENMABJun 29, 2022J A KEMPADMISSIBLE
PFIZERJun 29, 2022PFIZERADMISSIBLE

Patent Citations (18) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2013US21937
DESCRIPTIONUS2010239579
DESCRIPTIONUS5624659
DESCRIPTIONUS5945098
DESCRIPTIONUS6174708
DESCRIPTIONUS6187287
DESCRIPTIONWO2011143624
OPPOSITIONUS2011070269
OPPOSITIONUS2013309244
OPPOSITIONWO2009091601
OPPOSITIONWO2011136828
OPPOSITIONWO2013119714
OPPOSITIONWO2014179132
OPPOSITIONWO2015105995
OPPOSITIONWO2016118754
SEARCHUS2011070269
SEARCHUS2013309244
SEARCHWO2011136828

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents